Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
33.99
+0.12 (0.35%)
At close: Mar 9, 2026, 4:00 PM EDT
34.00
+0.01 (0.02%)
After-hours: Mar 9, 2026, 7:24 PM EDT
Corcept Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 120.5 | 127.67 | 135.55 | 66.33 | 77.62 | Upgrade
|
| Short-Term Investments | 251.66 | 255.67 | 232.67 | 365.34 | 145.92 | Upgrade
|
| Cash & Short-Term Investments | 372.15 | 383.33 | 368.22 | 431.67 | 223.54 | Upgrade
|
| Cash Growth | -2.92% | 4.10% | -14.70% | 93.11% | -49.28% | Upgrade
|
| Accounts Receivable | 59.79 | 53.98 | 41.12 | 31.06 | 27.63 | Upgrade
|
| Other Receivables | - | - | 14 | 15.8 | 1.4 | Upgrade
|
| Receivables | 59.79 | 53.98 | 55.12 | 46.86 | 29.03 | Upgrade
|
| Inventory | 12.87 | 12.41 | 7.73 | 6.1 | 4.99 | Upgrade
|
| Prepaid Expenses | 23.26 | 9.49 | 4.32 | 14.62 | 8.92 | Upgrade
|
| Other Current Assets | 17.4 | 12.39 | 23.24 | - | - | Upgrade
|
| Total Current Assets | 485.46 | 471.6 | 458.64 | 499.25 | 266.46 | Upgrade
|
| Property, Plant & Equipment | 6.47 | 8.01 | 0.32 | 1.78 | 1.52 | Upgrade
|
| Long-Term Investments | 160.27 | 219.83 | 57.18 | 4.95 | 112.28 | Upgrade
|
| Long-Term Deferred Tax Assets | 168.2 | 130.91 | 90.61 | 61.47 | 27.46 | Upgrade
|
| Other Long-Term Assets | 16.25 | 10.19 | 14.79 | 15.99 | 16.05 | Upgrade
|
| Total Assets | 836.65 | 840.55 | 621.52 | 583.43 | 423.76 | Upgrade
|
| Accounts Payable | 40.44 | 15.38 | 17.4 | 11.98 | 6.91 | Upgrade
|
| Accrued Expenses | 117.64 | 120.52 | 70.49 | 44.52 | 39.3 | Upgrade
|
| Current Portion of Leases | 1.08 | 0.83 | 0.15 | 1.14 | 0.53 | Upgrade
|
| Current Income Taxes Payable | - | - | 1.81 | 0.09 | 0.51 | Upgrade
|
| Other Current Liabilities | 6.91 | 4.04 | 14.65 | 14.76 | 0.3 | Upgrade
|
| Total Current Liabilities | 166.09 | 140.77 | 104.51 | 72.49 | 47.54 | Upgrade
|
| Long-Term Leases | 5.02 | 6.11 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 17.74 | 14.08 | 10.31 | 9.1 | 0.41 | Upgrade
|
| Total Liabilities | 188.85 | 160.96 | 114.81 | 81.59 | 47.95 | Upgrade
|
| Common Stock | 0.14 | 0.14 | 0.13 | 0.13 | 0.13 | Upgrade
|
| Additional Paid-In Capital | 968.6 | 832.11 | 738.52 | 662.34 | 591.35 | Upgrade
|
| Retained Earnings | 643.39 | 543.74 | 402.53 | 296.39 | 194.97 | Upgrade
|
| Treasury Stock | -966.59 | -696.17 | -635.08 | -456.15 | -410.41 | Upgrade
|
| Comprehensive Income & Other | 2.26 | -0.22 | 0.61 | -0.87 | -0.23 | Upgrade
|
| Shareholders' Equity | 647.81 | 679.59 | 506.71 | 501.84 | 375.81 | Upgrade
|
| Total Liabilities & Equity | 836.65 | 840.55 | 621.52 | 583.43 | 423.76 | Upgrade
|
| Total Debt | 6.11 | 6.94 | 0.15 | 1.14 | 0.53 | Upgrade
|
| Net Cash (Debt) | 526.32 | 596.23 | 425.25 | 435.48 | 335.29 | Upgrade
|
| Net Cash Growth | -11.73% | 40.21% | -2.35% | 29.88% | -29.32% | Upgrade
|
| Net Cash Per Share | 4.39 | 5.25 | 3.81 | 3.76 | 2.66 | Upgrade
|
| Filing Date Shares Outstanding | 106.37 | 105.5 | 103.52 | 107.9 | 105.96 | Upgrade
|
| Total Common Shares Outstanding | 105.97 | 105.11 | 103.41 | 107.84 | 105.94 | Upgrade
|
| Working Capital | 319.38 | 330.83 | 354.13 | 426.76 | 218.92 | Upgrade
|
| Book Value Per Share | 6.11 | 6.47 | 4.90 | 4.65 | 3.55 | Upgrade
|
| Tangible Book Value | 647.81 | 679.59 | 506.71 | 501.84 | 375.81 | Upgrade
|
| Tangible Book Value Per Share | 6.11 | 6.47 | 4.90 | 4.65 | 3.55 | Upgrade
|
| Machinery | - | - | - | - | 1.16 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 1.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.